Sarah Camille Glover

Sarah Camille Glover

Auto-generated profile, based on publicly available information

Sarah Camille Glover

Department of Medicine, Section of Gastroenterology, Tulane University, United States

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
UMUma Mahadevan
Uma Mahadevan
DWDouglas C. Wolf
Douglas C. Wolf
MDMarla Dubinsky
Marla Dubinsky
ACAntoine Cortot
Antoine Cortot
SLScott D. Lee
Scott D. Lee
MAMaria T. Abreu
Maria T. Abreu

17 October 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JLJonathan J Lyons
Jonathan J Lyons
XYXiaomin Yu
Xiaomin Yu
JHJason D Hughes
Jason D Hughes
QLQuang T Le
Quang T Le
AJAli Jamil
Ali Jamil
JMJoshua D Milner
Joshua D Milner

1 September 2021 in Cell
Verified
Journal Article
Open access
CZCarly G.K. Ziegler
Carly G.K. Ziegler
VMVincent N. Miao
Vincent N. Miao
AOAnna H. Owings
Anna H. Owings
ANAndrew W. Navia
Andrew W. Navia
YTYing Tang
Ying Tang
JOJose Ordovas-Montanes
Jose Ordovas-Montanes
SARS-CoV-2 infection can cause severe respiratory COVID-19. However, many individuals present with isolated upper respiratory symptoms, suggesting potential to constrain viral pathology to the nasopharynx. Which cells SARS-CoV-2 primarily targets and how infection influences the respiratory epithelium remains incompletely understood. We performed scRNA-seq on nasopharyngeal swabs from 58 healthy and COVID-19 participants. During COVID-19, we observe expansion of secretory, loss of ciliated, and epithelial cell repopulation via deuterosomal cell expansion. In mild and moderate COVID-19, epithelial cells express anti-viral/interferon-responsive genes, while cells in severe COVID-19 have muted anti-viral responses despite equivalent viral loads. SARS-CoV-2 RNA+ host-target cells are highly heterogenous, including developing ciliated, interferon-responsive ciliated, AZGP1high goblet, and KRT13+ “hillock”-like cells, and we identify genes associated with susceptibility, resistance, or infection response. Our study defines protective and detrimental responses to SARS-CoV-2, the direct viral targets of infection, and suggests that failed nasal epithelial anti-viral immunity may underlie and precede severe COVID-19.
1

1 December 2016 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
DSDror S. Shouval
Dror S. Shouval
ABAmlan Biswas
Amlan Biswas
YKYu Hui Kang
Yu Hui Kang
AGAlexandra E. Griffith
Alexandra E. Griffith
LKLiza Konnikova
Liza Konnikova
SSScott B. Snapper
Scott B. Snapper

11 July 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDaniel C Stewart
Daniel C Stewart
DBDalton Berrie
Dalton Berrie
JLJian Li
Jian Li
XLXinyue Liu
Xinyue Liu
CRCooper Rickerson
Cooper Rickerson
CSChelsey S Simmons
Chelsey S Simmons
Inflammatory bowel disease (IBD) continues to increase in prevalence in industrialized countries. Major complications of IBD include formation of fibrotic strictures, fistulas, reduced absorptive function, cancer risk, and the need for surgery. In other chronic gastrointestinal disease models, stiffness has been shown to precede fibrosis; therefore, stiffness may be a reasonable indicator of progression toward stricture formation in IBD patients. Herein, we seek to quantify tissue stiffness and characterize fibrosis in patients with IBD and to compare mechanical properties of unaffected human tissue to common animal species used for IBD studies. Inflamed and unaffected tissue from IBD patients and unaffected tissue from mice, pigs, and cows were indented using a custom device to determine the effective stiffness. Histology was performed on matched tissues, and total RNA was isolated from IBD tissue samples and used for gene expression analysis of pro-fibrotic genes. We observed an increase in the effective stiffness (steady-state modulus, SSM) (p < 0.0001) and increased expression of the collagen type I gene (COL1A1, p = 0.01) in inflamed tissue compared to unaffected areas in our IBD patient cohort. We also found that increased staining of collagen fibers in submucosa positively correlated with SSM (p = 0.093). We determined that unaffected animal bowel stiffness is significantly greater than similar human tissues, suggesting additional limitations on animal models for translational investigations regarding stiffness-related hypotheses. Taken together, our data support development of tools for evaluation of bowel stiffness in IBD patients for prognostic applications that may enable more accurate prediction of those who will develop fibrosis and more precise prescription of aggressive therapies.

1 November 2007 in Laboratory Investigation
Verified
Journal Article
Closed access
RVRamana Vishnubhotla
Ramana Vishnubhotla
SSShan Sun
Shan Sun
JHJameela Huq
Jameela Huq
MBMarinka Bulic
Marinka Bulic
ARAnil Ramesh
Anil Ramesh
SGSarah C Glover
Sarah C Glover